RETINORM FAMILY (OPHTHALMOLOGY – DRY & WET AMD, ANTIOXIDANT, FOOD SUPPLEMENT)

Levofloxacin-Dexamethasone eye drops solution is the first combination approved for the management of patients undergoing cataract surgery able to prevent infection and ensure complete control of inflammation with one week treatment. Levofloxacin-Dexamethasone combines the power of the most ac...

Ededay and Edenight are hypertonic products containing sodium hyaluronate 0.4% and hypertonic agents, indicated for the temporary relief of the symptoms of corneal edema. Ededay eye drops also contains sorbitol (13,5%) and can be used during the day.          Ed...

Allergix Free and Lertal spray are lubricating and lenitive ocular spray, containing liposomes, Perilla and sodium hyaluronate, three natural compounds with synergistic action for treating inflammation and allergic conjunctivitis symptoms. The combined action of liposomes and sodium hyaluronate helps t...

NTC S.r.l. offers a wide range of ophthalmic medical devices which includes hyaluronic acid at different dosages 0.10%, 0.15%, 0.2%, 0.4% and the addition of other components.
LUVIS:  Hyaluronic Acid eye drop solution is the ideal product for instantly soothing and hydrating dry eyes. Sodium Hyal...

Dexamethasone is a long-acting synthetic adrenocorticoid with intense anti-inflammatory activity Thanks to its properties, dexamethasone is useful in the management of steroid-responsive inflammatory conditions such as uveitis, allergic conjunctivitis, iritis, or cyclitis; symptomatic treatment of cor...

Ofloxacin is a second-generation fluoroquinolone. Levofloxacin is a third-generation fluoroquinolone and is the pure L-enantiomer of ofloxacin. 
Fluoroquinolones are broad spectrum bactericidal agents with activity against many of the important corneal pathogens including staphylococci, Ne...

TiAfemme is an innovative wipe based on TiAB (a patented complex of titanium dioxide with covalently linked monovalent silver ions) effective against many microorganisms, including aerobic, anaerobic, Gram-negative and Gram-positive bacteria, yeast, filamentous fungi and viruses. TiAfemme has been speci...

TiAB Vulvar Gel and Foam for vulvar discomfort are medical devices formulations based on TiAB, a patented complex of titanium dioxide with covalently linked monovalent silver ions, indicated as adjuvants in the treatment of vulvar contact dermatitis and discomfort.  

T...

TiAB vaginal gel combined components have a synergic activity in the treatment of vaginal symptoms in Genitourinary Syndrome in Menopause (GSM). Hyaluronic acid contributes to form a film on the vaginal mucosae creating the ideal environment to facilitate tissues reepithelization, the natural component...

GelFemme, based on ectoin and hyaluronic acid, is an adjuvant in the prevention and treatment of vaginal atrophy for women of all ages, allowing the maintenance of vaginal mucosa natural hydration and alleviating the symptoms of vaginal atrophy such as dryness, burning, itching and discomfort during se...

TiAb Urological Gel is a Medical Device indicated as adjuvant in the natural healing process of not complicated post-surgical lesions and as adjuvant in the treatment of viral, fungal and bacterial infections. It is a cream-gel made from TiAb (a patented complex of titanium dioxide with covalently link...

TIAHEM is a medical device adjuvant in the treatment of symptoms associated with hemorrhoidal disease  (external and internal hemorrhoids) such as pain, irritation and itching affecting anal area;  it promotes and accelerates normal repair and healing processes in case of haemorrhoids, anal f...

A pharmacovigilance study published confirms the safety of fixed-dose eye drops for post-cataract surgery 17 Jul, 2025A recently published five-year pharmacovigilance study confirms the excellent safety profile of a fixed-dose combination eye drop containing an anti-inflammatory steroid and a quinolone antibiotic, developed by NTC, indicated for the prevention and treatment of inflammation and prevention of infection following cataract surgery in adults. The study was submitted when nearly 4 million patients across about 60 countries worldwide were treated with this drug.

 

Advanced scientific research and technology drive our efforts to innovate care practices.
Our range of products builds from our historical vocation for innovation aimed at improving the experience of patients and healthcare practices.
An innovation aimed at discovering specific therapeutic gestures: simple and intuitive,  sustainable, and technically advanced for empowering the patient.
Our research aims to put pioneering new products within the reach of everyone and to optimize the
performance of our products by analyzing the daily needs and habits of people undergoing treatment.
We research, develop and produce innovative drugs, medical devices and food supplements.
We market our products worldwide through licensing, distribution, marketing, and commercial deals with partner companies.
Our core therapeutic areas are: Ophthalmology, Gastro-Metabolism, Pediatrics and Gynacology.

A new in vitro study shows that a 2% concentration of TiAB—a compound based on silver-bound titanium dioxide—is sufficient to exert strong bactericidal activity within 24 hours against Gram-negative bacteria and support wound healing.

It describes our 2024 journey

Our products 

NTC: Novelty

NTC Technology

NTC Care